Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1356 per EA under NDC 51991052601. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 4, 2010.
Strength
250 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991052601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077714FDA Approved
6/4/2010
On Market Since
12/27/2010
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1356 per EA |
|---|---|
| All-time high | $0.1869 (Apr 16, 2014) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1324 |
| Median price | $0.1550 |
| Average price | $0.1557 |
| Largest weekly change | -21.3% (Aug 19, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1356 per EA (NDC 51991052601), effective Aug 19, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 13.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1869 (Apr 16, 2014), with a median of $0.1550 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TERBINAFINE HCL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 51991052601) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.